Chemoinformaics analysis of Spinacetin-3-O-Beta-D-Glucopyranosyl(1,6)-Beta-D-Glucopyranoside
Molecular Weight | 670.573 | nRot | 9 |
Heavy Atom Molecular Weight | 636.301 | nRig | 30 |
Exact Molecular Weight | 670.174 | nRing | 5 |
Solubility: LogS | -3.223 | nHRing | 3 |
Solubility: LogP | -1.245 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 2 |
nHetero | 18 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 18 | No. of Arom Bond | 17 |
nHA | 18 | APOL | 85.537 |
nHD | 10 | BPOL | 47.129 |
QED | 0.113 |
Synth | 4.86 |
Natural Product Likeliness | 1.784 |
NR-PPAR-gamma | 0.941 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.992 |
HIA | 0.958 |
CACO-2 | -6.382 |
MDCK | 0.0000593 |
BBB | 0.28 |
PPB | 0.707065 |
VDSS | 0.595 |
FU | 0.304019 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.063 |
CYP2c19-inh | 0.004 |
CYP2c19-sub | 0.064 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.157 |
CYP2d6-inh | 0.001 |
CYP2d6-sub | 0.158 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.003 |
CL | 1.405 |
T12 | 0.468 |
hERG | 0.073 |
Ames | 0.752 |
ROA | 0.035 |
SkinSen | 0.019 |
Carcinogencity | 0.041 |
EI | 0.006 |
Respiratory | 0.01 |
NR-Aromatase | 0.842 |
Antiviral | Yes |
Prediction | 0.680775 |